Key result
Ginkgo biloba extracts show preliminary promise in cardiovascular disease, but robust clinical trials remain needed.
Answers are grounded in this paper and cite their sources.
Results from clinical trials demonstrate that standardized leaf extracts of Ginkgo biloba (SGB extract) reduce the symptoms of age-associated memory impairment and dementia, including Alzheimer's disease, and may be of benefit in treating intermittent claudication. In addition, preliminary results suggest that SGB extract may be useful in preventing and treating cardiovascular disease (CVD). particularly ischemic cardiac syndrome. Since many patients with cardiovascular disease are already taking anticoagulants and antiplatelet drugs, self-medication with SGB extract is not recommended without the advice of their physician. Although SGB extracts look promising for preventing and treating CVD, well-controlled clinical trials are needed before clinical recommendations can be made.
No takes yet. Share an insight, caveat, or question.
Gail B. Mahady (2002) conducted a review in Cardiovascular disease (including ischemic cardiac syndrome and intermittent claudication), age-associated memory impairment, and dementia. Standardized leaf extracts of Ginkgo biloba (SGB extract) was evaluated on Prevention and treatment of cardiovascular disease. Standardized leaf extracts of Ginkgo biloba show preliminary promise for preventing and treating cardiovascular disease, though well-controlled clinical trials are still needed.
Synapse has enriched 5 related papers. Consider them for comparative context: